Back

Prognostic value of right and left heart functional parameters and levels of biomarkers in chronic heart failure patients with preserved, mid-ranged and reduced ejection fraction

27 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2018

About the speaker

Photo
Professor Liana Tumasyan

Institute of Cardiology of Yerevan, Yerevan (Armenia)

30 More presentations in this session

Presentation thumbnail
Doctor Y. Chia (Singapore, SG)
Abstract Slides
Presentation thumbnail
Mr V. Martinez Mateo (Alcazar de San Juan, ES)
Abstract Slides
Presentation thumbnail
Professor A. Grupper (Beer Yakov, IL)
Abstract Slides
Presentation thumbnail
Doctor O. Manintveld (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Doctor E. Cabrera Romero (Murcia, ES)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome

The Event

Event poster

Heart Failure 2018

27 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Integration of echocardiographic and biomarker parameters for functional stratification and risk prediction in HFpEF patients
13 December 2025
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
13 May 2024
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
19 September 2025
thumbnail
Congress Presentation
Comparative efficacy of renin-angiotensin aldosteron system modulators and angiotensin receptor neprilyzin inhibitor in chronic heart failure with reduced, mid-ranged and preserved ejection fraction
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources